跳转至内容
Merck
CN
  • Development of homogeneous plasmonic potency assay using gold nanoparticle immunocomplexes.

Development of homogeneous plasmonic potency assay using gold nanoparticle immunocomplexes.

Journal of pharmaceutical and biomedical analysis (2020-01-27)
Jin-Hee Han, Fang Li, Rico C Gunawan
摘要

We evaluated the use of gold nanoparticles (AuNPs) platform in a homogenous assay for a potency measurement of a therapeutic monoclonal antibody (mAb). The recombinant human ligand protein to the therapeutic mAb was immobilized on AuNPs via functionalized self-assembled monolayers. Binding of the mAb to ligand lead to plasmonic signals that were detected faster in a homogeneous assay than the conventional enzyme-linked immunosorbent assay (ELISA). In this study, we demonstrated that the AuNP-based homogeneous plasmonic immunoassay (HPI) generated comparable potency values of a therapeutic mAb to a conventional binding ELISA in relatively shorter assay time and steps. Binding HPI can be potentially implemented as a potency assay for therapeutic mAbs in quality control laboratories.

材料
货号
品牌
产品描述

Sigma-Aldrich
白蛋白 溶液 来源于牛血清, 35% in DPBS, sterile-filtered, BioXtra, suitable for cell culture
Sigma-Aldrich
氯化镍(II) 六水合物, puriss. p.a., ≥98%
Sigma-Aldrich
双(3-磺基-N-羟基琥珀酰亚胺酯)辛二酸酯 钠盐, ≥95% (H-NMR), powder
Sigma-Aldrich
金纳米颗粒, 5 nm, NHS ester functionalized, conjugation kit
Sigma-Aldrich
金纳米颗粒, 40 nm, NHS ester functionalized, conjugation kit
Sigma-Aldrich
金纳米颗粒, 10 nm, NHS ester functionalized, conjugation kit